PUBLISHED DATE : Jan 2022 | Pages : 188
Fill out your details & get your free sample
U.S. E-Prescribing Market Size, Share, & Trends Analysis Report by
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2022–2027.
188 Pages
45 Tables
85 Charts
1 Regions
1 Countries
30 Companies
5 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (REVENUE) | USD 1234.27 MILLION (2027) |
| CAGR (REVENUE) | 20.68% (2022-2027) |
| BASE YEAR | 2021 |
| FORECAST PERIOD | 2022 – 2027 |
| MARKET SEGMENTS | Type (Standard E-prescribing, and EPCS), Delivery Mode (Web & Cloud-Based, and On-Premises and Desktop), Modality (Integrated, and Standalone), Medication Type (Cardiovascular, Oncology, Anti-Infectives, Behavioural and Mental Health, Pain Medication, and Others), and End-user (Healthcare facilities, EHR, Telehealth & Pharmacy Software Vendors, Independent and Speciality Pharmacies, Pharmacy benefit managers (PBM) and Payors) |
| GEOGRAPHICAL ANALYSIS | U.S. |
The U.S. E-prescribing market size was valued at USD 399.59 million in 2021 and is expected to reach USD 1,234.27 million by 2027, growing at a CAGR of 20.68%. E-prescribing uses healthcare technologies to improve prescription accuracy, enhance patient safety, and ensure cost savings. Also, e-prescribing allows real-time, secure, and bi-directional electronic connectivity between prescribers and pharmacies.
Telehealth in the country is also growing rapidly as healthcare providers are implementing more sophisticated health IT infrastructures. The rise in third-party vendors offering add-on telehealth services and advancing practice management tools are allowing to integrate more consults into providers’ workflow, and these advancements will boost the e-prescribing services in the market.
SNIPPETS
U.S. E-PRESCRIBING MARKET SEGMENTATION
This research report includes a detailed segmentation by:
SEGMENTATION ANALYSIS
VENDOR ANALYSIS
The U.S. e-prescribing market report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:
By Type
By Delivery Mode
By Modality
By Medication Type
By End-User
Frequently Asked Questions
How big is the U.S. e-prescribing market?
The U.S. e-prescribing market was valued at USD 399.59 million in 2021 and is expected to reach USD 1234.27 million by 2027.
What are the factors driving the U.S. e-prescribing market?
Low cost, accessibility, value-based care model, financial incentives, innovation, health care efficiency, improved communication between providers, payers, and patients are some of the factors driving the U.S. e-prescribing market.
Who are the key players in the e-prescribing market in the U.S.?
Key Players include Athenahealth, Cerner Corporation, DrFirst, Henry Schein, Inc., InSync Healthcare Solutions, Practice Fusion Inc., Surescripts.
Who are the end-users in the e-prescribing market in the U.S.?
Healthcare facilities, EHR, telehealth & pharmacy software vendors, independent specialty pharmacies, and PBM & payors are the key end-users in the e-prescribing market in the U.S.
Which segment has the highest share in the U.S. e-prescribing market?
Based on type, the standard e-prescribing segment accounted for the major share of 92.82% in 2021 and is anticipated to retain its market dominance during the forecast period.
The U.S. e-prescribing market by revenue is expected to grow at a CAGR of 20.68% during the period 2022–2027.
Base Year: 2021
Forecast year: 2022-2027
The report considers the present scenario of the U.S. e-prescribing market and its market dynamics for the period 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply side of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.
Prominent Vendors
Other Prominent Vendors
Market Segmentation by Type
Market Segmentation by Delivery Mode
Market Segmentation by Modality
Market Segmentation by Medication Type
Market Segmentation by End-User
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope Of The Study
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
7.1.1 Features Of An Ideal Electronic Prescribing System
7.1.2 Standards For Electronic Prescription Systems
7.1.3 Covid-19 Impact On E-Prescribing In US
8 Market Opportunities & Trends
8.1 Investment In Digital Health & Uptake Of Telehealth Services
8.2 AI To Eradicate Prescription Errors & Develop Indication-Based Prescribing Systems
8.3 Fueling EHR Innovation By Outsourcing E-Prescribing
8.4 Advancements In E-Prescribing Solutions
9 Market Growth Enablers
9.1 Monitoring Use Of Controlled Substances
9.2 Government Initiatives & Incentive Programs For Adopting E-Prescribing
9.3 Automating Clinical Support Decisions & Reducing Manual Prescription Errors
10 Market Growth Restraints
10.1 High Cost Of Deployment & Inadequate Security Concerns
10.2 Incompatible Software Systems & Complex Technologies
10.3 Absence Of Standardized Competence Leading To E-Formulary Errors
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 E-prescribing Type
11.2.2 Delivery Mode
11.2.3 Modality
11.2.4 Medication
11.2.5 End-users
11.3 FIVE FORCES ANALYSIS
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Type
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Standard E-Prescribing
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 EPCS
12.4.1 Market Overview
12.4.2 Market Size & Forecast
13 Delivery Mode
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Web- & Cloud-Based
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 On-Premise & Desktop
13.4.1 Market Overview
13.4.2 Market Size & Forecast
14 Modality
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Integrated
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Standalone
14.4.1 Market Overview
14.4.2 Market Size & Forecast
15 Medication Type
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Cardiovascular
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.4 Oncology
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.5 Anti-Infectives
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.6 Behavioral & Mental Health
15.6.1 Market Overview
15.6.2 Market Size & Forecast
15.7 Pain Medication
15.7.1 Market Overview
15.7.2 Market Size & Forecast
15.8 Others
15.8.1 Market Overview
15.8.2 Market Size & Forecast
16 End-User
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Healthcare Facilities
16.3.1 Market Overview
16.3.2 Market Size & Forecast
16.4 EHR, Telehealth, & Pharmacy Software Vendors
16.4.1 Market Overview
16.4.2 Market Size & Forecast
16.5 Independent & Specialty Pharmacies
16.5.1 Market Overview
16.5.2 Market Size & Forecast
16.6 PBM & Payors
16.6.1 Market Overview
16.6.2 Market Size & Forecast
17 Competitive Landscape
17.1 Competition Overview
17.2 Market Share Analysis
17.2.1 Surescripts in E-prescribing Market
17.2.2 DrFirst in E-prescribing Market
17.2.3 Practice Fusion in E-prescribing Market
17.2.4 InSync Healthcare Solutions in E-prescribing Market
18 Key Company Profiles
18.1 ATHENAHEALTH
18.1.1 Business Overview
18.1.2 Product Offerings
18.1.3 Key Strategies
18.1.4 Key Strengths
18.1.5 Key Opportunities
18.2 CERNER CORPORATION
18.2.1 Business Overview
18.2.2 Product Offerings
18.2.3 Key Strategies
18.2.4 Key Strengths
18.2.5 Key Opportunities
18.3 DRFIRST
18.3.1 Business Overview
18.3.2 Product Offerings
18.3.3 Key Strategies
18.3.4 Key Strengths
18.3.5 Key Opportunities
18.4 HENRY SCHEIN INC.
18.4.1 Business Overview
18.4.2 Product Offerings
18.4.3 Key Strategies
18.4.4 Key Strengths
18.4.5 Key Opportunities
18.5 INSYNC HEALTHCARE SOLUTIONS
18.5.1 Business Overview
18.5.2 Product Offerings
18.5.3 Key Strategies
18.5.4 Key Strengths
18.5.5 Key Opportunities
18.6 PRACTICE FUSION
18.6.1 Business Overview
18.6.2 Product Offerings
18.6.3 Key Strategies
18.6.4 Key Strengths
18.6.5 Key Opportunities
18.7 SURESCRIPTS
18.7.1 Business Overview
18.7.2 Product Offerings
18.7.3 Key Strategies
18.7.4 Key Strengths
18.7.5 Key Opportunities
19 Other Prominent Vendors
19.1 ADVANCEDMD
19.1.1 Business Overview
19.1.2 Product Offerings
19.2 AEGIS HEALTHCARE
19.2.1 Business Overview
19.2.2 Product Offerings
19.3 ALLSCRIPTS HEALTHCARE
19.3.1 Business Overview
19.3.2 Product Offerings
19.4 BIZMATICS
19.4.1 Business Overview
19.4.2 Product Offerings
19.5 BRAVADO HEALTH
19.5.1 Business Overview
19.5.2 Product Offerings
19.6 CARECLOUD
19.6.1 Business Overview
19.6.2 Product Offerings
19.7 CHANGE HEALTHCARE
19.7.1 Business Overview
19.7.2 Product Offerings
19.8 CHETU
19.8.1 Business Overview
19.8.2 Product Offerings
19.9 CREDIBLE
19.9.1 Business Overview
19.9.2 Product Offerings
19.10 DAW SYSTEMS
19.10.1 Business Overview
19.10.2 Product Offerings
19.11 DOSESPOT
19.11.1 Business Overview
19.11.2 Product Offerings
19.12 DRCHRONO
19.12.1 Business Overview
19.12.2 Product Offerings
19.13 ECLINICALWORKS
19.13.1 Business Overview
19.13.2 Product Offerings
19.14 EMDS
19.14.1 Business Overview
19.14.2 Product Offerings
19.15 KAREO
19.15.1 Business Overview
19.15.2 Product Offerings
19.16 MDTOOLBOX
19.16.1 Business Overview
19.16.2 Product Offerings
19.17 MEDICAL INFORMATION TECHNOLOGY INC.
19.17.1 Business Overview
19.17.2 Product Offerings
19.18 NEXTGEN HEALTHCARE
19.18.1 Business Overview
19.18.2 Product Offerings
19.19 RXNT
19.19.1 Business Overview
19.19.2 Product Offerings
19.20 SISGAIN
19.20.1 Business Overview
19.20.2 Product Offerings
19.21 STREAMLINE HEALTHCARE SOLUTIONS
19.21.1 Business Overview
19.21.2 Product Offerings
19.22 TENELEVEN GROUP
19.22.1 Business Overview
19.22.2 Product Offerings
19.23 WEBPT
19.23.1 Business Overview
19.23.2 Product Offerings
20 Report Summary
20.1 Key Takeaways
20.2 Strategic Recommendations
21 Quantitative Summary
21.1 Market By Type
21.2 Market By Delivery Mode
21.3 Market By Modality
21.4 Market By Medication Type
21.5 Market By End-User
22 Appendix
22.1 Abbreviations
LIST OF EXHIBITS
Exhibit 1 Segmentation of US E-prescribing Market
Exhibit 2 US E-prescribing Market Size Calculation Approach 2021
Exhibit 3 Graduated Levels of Electronic Prescribing
Exhibit 4 Impact of Investment in Digital Health & Uptake of Telehealth Services
Exhibit 5 Impact of AI to Eradicate Prescription Errors & Develop Indication-based Prescribing Systems
Exhibit 6 Impact of Fueling EHR Innovation by Outsourcing E-prescribing
Exhibit 7 EHR Adoption Rate in US (%)
Exhibit 8 Impact of Advancements in E-prescribing Solutions
Exhibit 9 EHR to E-prescribing: Timeline of Development
Exhibit 10 Evolution of E-prescribing
Exhibit 11 Impact of Monitoring Use of Controlled Substances
Exhibit 12 Electronic Prescribing of Controlled Substances: Statistics
Exhibit 13 Impact of Government Initiatives & Incentive Programs for Adopting E-prescribing
Exhibit 14 Impact of Automation of Clinical Support Decision & Reducing Manual Prescription Errors
Exhibit 15 Impact of High Cost of Deployment & Inadequate Security Concerns
Exhibit 16 Impact of Incompatible Software Systems & Complex Technologies
Exhibit 17 Impact of Absence of Standardized Competence Leading to E-formulary Errors
Exhibit 18 US E-prescribing Market 2021–2027 ($ million)
Exhibit 19 US E-prescribing Market by Type
Exhibit 20 US E-prescribing Market by Delivery Mode
Exhibit 21 US E-prescribing Market by Modality
Exhibit 22 US E-prescribing Market by Medication Type
Exhibit 23 US E-prescribing Market by End-user
Exhibit 24 Five Forces Analysis 2021
Exhibit 25 Incremental Growth by Type 2021 & 2027
Exhibit 26 US E-prescribing Market by Type
Exhibit 27 US E-prescribing Market by Type: Incremental Growth
Exhibit 28 US E-prescribing Market by Type: Absolute Growth
Exhibit 29 Number of E-prescriptions by Surescripts (billion)
Exhibit 30 US Standard E-prescribing Market: Incremental & Absolute Growth
Exhibit 31 E-prescribing by Pharmacies & Prescribers (%)
Exhibit 32 US Standard E-prescribing Market 2021–2027 ($ million)
Exhibit 33 Surescripts Generated E-prescribing for Controlled Substances (million)
Exhibit 34 E-prescribing for Controlled Substances by Pharmacies & Prescribers (%)
Exhibit 35 US EPCS E-prescribing Market: Incremental & Absolute Growth
Exhibit 36 US EPCS E-prescribing Market 2021–2027 ($ million)
Exhibit 37 Incremental Growth by Delivery Mode 2021 & 2027
Exhibit 38 US E-prescribing Market by Delivery Mode
Exhibit 39 US E-prescribing Market by Delivery Mode: Incremental Growth
Exhibit 40 US E-prescribing Market by Delivery Mode: Absolute Growth
Exhibit 41 US Web- & Cloud-based E-prescribing Market: Incremental & Absolute Growth
Exhibit 42 US Web- & Cloud-based E-prescribing Market 2021–2027 ($ million)
Exhibit 43 US On-premise & Desktop E-prescribing Market: Incremental & Absolute Growth
Exhibit 44 US On-premise & Desktop E-prescribing Market 2021–2027 ($ million)
Exhibit 45 Incremental Growth by Modality 2021 & 2027
Exhibit 46 US E-prescribing Market by Modality
Exhibit 47 US Modality E-prescribing Market: Incremental Growth
Exhibit 48 US Modality E-prescribing Market: Absolute Growth
Exhibit 49 US Integrated Modality E-prescribing Market: Incremental & Absolute Growth
Exhibit 50 US Integrated E-prescribing Market 2021–2027 ($ million)
Exhibit 51 US Standalone E-prescribing Market: Incremental & Absolute Growth
Exhibit 52 US Standalone E-prescribing Market 2021–2027 ($ million)
Exhibit 53 Incremental Growth by Medication Type 2021 & 2027
Exhibit 54 US E-prescribing Market by Medication Type
Exhibit 55 E-prescribing Usage in Various Classes of Medication (%)
Exhibit 56 Top Five Specialties Using EPCS (2019)
Exhibit 57 US E-prescribing Market by Medication Type: Incremental Growth
Exhibit 58 US E-prescribing Market by Medication Type: Absolute Growth
Exhibit 59 US Cardiovascular E-prescribing Market: Incremental & Absolute Growth
Exhibit 60 US Cardiovascular E-prescribing Market 2021–2027 ($ million)
Exhibit 61 US Oncology E-prescribing Market: Incremental & Absolute Growth
Exhibit 62 US Oncology E-prescribing Market 2021–2027 ($ million)
Exhibit 63 US Anti-infectives E-prescribing Market: Incremental & Absolute Growth
Exhibit 64 US Anti-infectives E-prescribing Market 2021–2027 ($ million)
Exhibit 65 US Behavioral & Mental Health E-prescribing Market: Incremental & Absolute Growth
Exhibit 66 US Behavioral & Mental Health E-prescribing Market 2021–2027 ($ million)
Exhibit 67 E-prescribing Opioids by Surescripts in US (million)
Exhibit 68 Top Five Opioid E-prescription by Surescripts (2019)
Exhibit 69 US Pain Medication E-prescribing Market: Incremental & Absolute Growth
Exhibit 70 US Pain Medication E-prescribing Market 2021–2027 ($ million)
Exhibit 71 US Other E-prescribing Market: Incremental & Absolute Growth
Exhibit 72 US Other E-prescribing Market 2021–2027 ($ million)
Exhibit 73 Incremental Growth by End-user 2021 & 2027
Exhibit 74 US E-prescribing Market by End user
Exhibit 75 US End-user E-prescribing Market: Incremental Growth
Exhibit 76 US End-user E-prescribing Market: Absolute Growth
Exhibit 77 US Healthcare Facilities E-prescribing Market: Incremental & Absolute Growth
Exhibit 78 US Healthcare Facilities E-prescribing Market 2021–2027 ($ million)
Exhibit 79 US EHR, Telehealth, & Pharmacy Software Vendors E-prescribing Market: Incremental & Absolute Growth
Exhibit 80 US EHR, Telehealth, & Pharmacy Software Vendors E-prescribing Market 2021–2027 ($ million)
Exhibit 81 E-prescribing Specialty Drugs as Percentage of Total Drug Spend
Exhibit 82 US Independent & Specialty Pharmacies E-prescribing Market: Incremental & Absolute Growth
Exhibit 83 US Independent & Specialty Pharmacies E-prescribing Market 2021–2027 ($ million)
Exhibit 84 US PBM & Payors E-prescribing Market: Incremental & Absolute Growth
Exhibit 85 US PBM & Payors E-prescribing Market 2021–2027 ($ million)
LIST OF TABLES
Table 1 Key Caveats
Table 2 Currency Conversion 2015−2021
Table 3 Cost Associated with Basic E-prescribing & EPCS in EHRs
Table 4 Consequences of E-prescribing Errors
Table 5 Pros & Cons of Standalone & Integrated E-prescribing Solutions
Table 6 Athenahealth: Major Product Offerings
Table 7 Cerner Corporation: Major Product Offerings
Table 8 DrFirst: Major Product Offerings
Table 9 Henry Schein Inc.: Major Product Offerings
Table 10 InSync Healthcare Solutions: Major Product Offerings
Table 11 Practice Fusion: Major Product Offerings
Table 12 Surescripts: Major Product Offerings
Table 13 AdvancedMD: Major Product Offerings
Table 14 Aegis Healthcare: Major Product Offerings
Table 15 Allscripts Healthcare: Major Product Offerings
Table 16 Bizmatics: Major Product Offerings
Table 17 Bravado Health: Major Product Offerings
Table 18 CareCloud: Major Product Offerings
Table 19 Change Healthcare: Major Product Offerings
Table 20 Chetu: Major Product Offerings
Table 21 Credible: Major Product Offerings
Table 22 Daw Systems: Major Product Offerings
Table 23 DoseSpot: Major Product Offerings
Table 24 DrChrono: Major Product Offerings
Table 25 eClinicalWorks: Major Product Offerings
Table 26 eMDs: Major Product Offerings
Table 27 Kareo: Major Product Offerings
Table 28 MDToolbox: Major Product Offerings
Table 29 Medical Information Technology Inc.: Major Product Offerings
Table 30 NextGen Healthcare: Major Product Offerings
Table 31 RXNT: Major Product Offerings
Table 32 SISGAIN: Major Product Offerings
Table 33 Streamline Healthcare Solutions: Major Product Offerings
Table 34 TenEleven Group: Major Product Offerings
Table 35 WebPT: Major Product Offerings
Table 36 US E-prescribing Market by Type 2021–2027 ($ million)
Table 37 US E-prescribing Market by Type 2021–2027 (%)
Table 38 US E-prescribing Market by Delivery Mode 2021–2027 ($ million)
Table 39 US E-prescribing Market by Delivery Mode 2021–2027 (%)
Table 40 US E-prescribing Market by Modality 2021–2027 ($ million)
Table 41 US E-prescribing Market by Modality 2021–2027 (%)
Table 42 US E-prescribing Market by Medication Type 2021–2027 ($ million)
Table 43 US E-prescribing Market by Medication Type 2021–2027 (%)
Table 44 US E-prescribing Market by End-user 2021–2027 ($ million)
Table 45 US E-prescribing Market by End-user 2021–2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
